로드 중...

Advertisement

Amgen To Open Manufacturing Site In Central Ohio; To Offer 400 Full-time Jobs

RTTNews | 458 일 전

Amgen To Open Manufacturing Site In Central Ohio; To Offer 400 Full-time Jobs

(RTTNews) - Amgen, Inc. (AMGN) announced Monday the opening of its manufacturing site in Central Ohio, the newest in its global operations network and the most advanced facility to date.

The nearly 300,000-square-foot facility will employ 400 full-time staff. It also features open workspaces to foster collaboration and has been designed to meet the highest environmental sustainability standards, in support of Amgen's commitment to achieve carbon neutrality for all operations by 2027.

In partnership with Columbus State Community College, Amgen is hosting an inaugural 18-month manufacturing apprenticeship at the site. This program, designed for those new to the field or changing careers, offers a blend of classroom and practical training, aiming to expand opportunities for skilled individuals without the requirement for a formal bachelor's degree.

태그 : AMGN

read more

Amgen's Bkemv Approved As First Interchangeable Biosimilar To Soliris

Amgen's Bkemv Approved As First Interchangeable Biosimilar To Soliris

The U.S. Food and Drug Administration has approved Amgen Inc.'s Bkemv (eculizumab-aeeb) as the first interchangeable biosimilar to Soliris (eculizumab), developed by British drug major AstraZeneca's Rare Disease unit Alexion Pharmaceuticals, to treat certain rare diseases. Soliris is a medicine used to treat adults and children with paroxysmal nocturnal haemoglobinuria or PNH...

RTTNews | 364 일 전

Amgen Says FDA Completes Review Of SNDA Seeking Full Approval For LUMAKRAS

Amgen Says FDA Completes Review Of SNDA Seeking Full Approval For LUMAKRAS

Amgen, Inc. (AMGN) announced Tuesday that the U.S. Food and Drug Administration (FDA) has completed its review of the company's supplemental New Drug Application seeking full approval of LUMAKRAS (sotorasib).

RTTNews | 520 일 전

Amgen, Horizon Therapeutics Reach Settlement On FTC Lawsuit; Seeks To Close Acquisition In Q4

Amgen, Horizon Therapeutics Reach Settlement On FTC Lawsuit; Seeks To Close Acquisition In Q4

Amgen (AMGN) and Horizon Therapeutics plc (HZNP) announced Friday the entry into a consent order agreement with the Federal Trade Commission (FTC) that resolves the pending FTC administrative lawsuit. This clears the path to take the final steps to close Amgen's $27.8 billion acquisition of Horizon.

RTTNews | 636 일 전

Amgen Announces Positive Top-line Results From Phase 3 DAHLIA Study Of ABP 959

Amgen Announces Positive Top-line Results From Phase 3 DAHLIA Study Of ABP 959

Amgen, Inc. (AMGN) announced Tuesday positive top-line results from the DAHLIA study, a randomized, double-blind, active-controlled, two-period crossover Phase 3 study evaluating the efficacy and safety of ABP 959, a biosimilar candidate to SOLIRIS (eculizumab), compared with SOLIRIS in adult patients with paroxysmal nocturnal hemoglobinuria (PNH).

RTTNews | 1010 일 전

Japan Retail Sales Climb 3.3% On Year In April

Japan Retail Sales Climb 3.3% On Year In April

The value of retail sales in Japan was up 3.3 percent on year in April, the Ministry of Economy, Trade and Industry said on Friday - coming in at 12.925 trillion yen.

RTTNews | 14 분 전

Japan Industrial Output Slips 0.9% In April

Japan Industrial Output Slips 0.9% In April

Industrial production in Japan was down 0.9 percent on month in April, the Ministry of Economy, Trade and Industry said on Friday.

RTTNews | 19 분 전

Win Streak May Continue For Singapore Stock Market

Win Streak May Continue For Singapore Stock Market

The Singapore stock market has moved higher in three straight sessions, advancing more than 40 points or 1 percent along the way. The Straits Times Index now sits just above the 3,915-point plateau and it may add to its winnings again on Friday.

RTTNews | 28 분 전

Japan Jobless Rate Holds Steady At 2.5%

Japan Jobless Rate Holds Steady At 2.5%

The unemployment rate in Japan came in at a seasonally adjusted 2.5 percent in April, the Ministry of Internal Affairs and Communications said on Friday.

RTTNews | 47 분 전

이용 약관 | 개인 정보 보호 | 사이트 맵 | Site Map Calendar

© 2025 Myfxbook Ltd. 모든 권리 보유.

고위험 경고: 외환 거래는 모든 투자자에게 적합하지 않을 수 있는 높은 수준의 위험을 수반합니다. 레버리지는 추가적인 위험 및 손실 노출을 만듭니다. 외환 거래를 결정하기 전에 투자 목표, 경험 수준 및 위험 허용 오차를 신중하게 고려하십시오. 초기 투자의 일부 또는 전부를 잃을 수 있습니다. 잃을 여유가 없는 돈을 투자하지 마십시오. 외환 거래와 관련된 위험에 대해 스스로 교육하고 궁금한 점이 있으면 독립 금융 또는 세무사에게 조언을 구하십시오. 모든 데이터 및 정보는 정보 제공 목적으로만 있는 그대로 제공되며 거래 목적이나 조언을 위한 것이 아닙니다. 과거의 성과는 미래의 결과를 나타내는 것이 아닙니다.